Cue Health to develop Omicron genotyping COVID-19 test and other digital health briefs
Mobi Health News
JANUARY 6, 2022
Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.
Let's personalize your content